08. January 2016

DAV132 is a product designed as a prophylactic treatment intended to prevent the development of Clostridium difficile infection, by binding with and neutralizing common antibiotics in the gut. DAV132 more generally preserves the integrity of the intestinal microbiota during antibiotic cures.It has two clinical objectives: Prevent the occurrence and recurrence of C. difficile infections in high risk patients receiving antibiotics such as oral and parenteral fluoroquinolones and cephalosporins;...

21. September 2015

Moisture absorbent additives are often needed in situations where hydrophilic active pharmaceutical ingredients (API) are processed. These kind of API’s (e.g. amino acids) absorb humidity from the ambient air. Therefore the particles of other ingredients in your tablet mass will stick to the API. Clumping inside the tableting mass will lead to an inhomogeneity and fluctuations of the tablethardness during the compaction process. More